Agrawal U,Katikireddi SV,McCowan C,Mulholland RH,Azcoaga-Lorenzo A,Amele S,Fagbamigbe AF,Vasileiou E,Grange Z,Shi T .2021 .COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): A prospective cohort study. Lancet Respir. Med, 9(12) : 1439-1449.
Ahsan T,Sajib AA .2021 .Repurposing of approved drugs with potential to interact with SARS-CoV-2 receptor. Biochem. Biophys. Rep, 26 : 100982.
Ameen F,Mamidala E,Davella R,Vallala S R .2021 .Rilpivirine inhibits SARS-CoV-2 protein targets: A potential multi-target drug. J. Infect. Public Health, 14(10) : 1454-1460.
Bassi LL. Hwenda L .2020 .COVID-19: time to plan for prompt universal access to diagnostics and treatments. Lancet Glob. Health, 8(6) : e756-e757.
Bochevarov AD,Harder E,Hughes TF,Greenwood JR,Braden DA,Philipp DM,Rinaldo D,Halls MD,Zhang J,Friesner RA .2013 .Jaguar: A high-performance quantum chemistry software program with strengths in life and materials sciences. Int. J. Quantum Chem, 113(18) : 2110-2142.
Bowers KJ,Chow DE,Xu H,Dror RO,Eastwood MP,Gregersen BA,Klepeis JL,Kolossvary I,Moraes MA,Sacerdoti FD .2006 .Scalable algorithms for molecular dynamics simulations on commodity clusters. SC'06: Proceedings of the 2006 ACM/IEEE Conference on Supercomputing, IEEE, : 43.
Cecon E,Burridge M,Cao L,Carter L,Ravichandran R,Dam J,Jockers R .2021 .SARS-COV-2 spike binding to ACE2 in living cells monitored by TRFRET. Cell Chem, 28 : 1-10.
Choudhury C .2021 .Fragment tailoring strategy to design novel chemical entities as potential binders of novel corona virus main protease. J. Biomol. Struct. Dyn., 39(10) : 3733-3746.
Dixon SL,Smondyrev AM,Knoll EH,Rao SN,Shaw DE. Friesner RA .2006 .PHASE: A new engine for pharmacophore perception, 3D QSAR model development and 3D database screening: 1. Methodology and preliminary results. J. Comput. Aided Mol. Des, 20(10) : 647-671.
Elbadwi FA,Khairy EA,Alsamani FO,Mahadi MA,Abdalrahman SE,Ahmed ZAM,Elsayed I,Ibraheem W,Alzain AA .2021 .Identification of novel transmembrane Protease Serine Type 2 drug candidates for COVID-19 using computational studies. Inform. Med, 26 : 100725.
Ertl P and Schuffenhauer A .2009 .Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions. J. Cheminform., 1(1) : 8.
Fadaka AO,Aruleba RT,Sibuyi NRS,Klein A,Madiehe AM,Meyer M,Biomol M .2020 .Inhibitory potential of repurposed drugs against the SARS-CoV-2 main protease: A computational-aided approach. , : 1-13.
Friesner RA,Murphy RB,Repasky MP,Frye LL,Greenwood JR,Halgren TA,Sanschagrin PC. Mainz DT .2006 .Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein- ligand complexes. J. Med, 49(21) : 6177-6196.
Giofrè SV,Napoli E,Iraci N,Speciale A,Cimino F,Muscarà C,Molonia MS,Ruberto G,Saija A .2021 .Interaction of selected terpenoids with two SARS-CoV-2 key therapeutic targets: An in silico study through molecular docking and dynamics simulations. Comput. Biol. Med, 134 : 104538.
Gobeil SM,Janowska K,McDowell S,Mansouri K,Parks R,Manne K,Stalls V,Kopp MF,Henderson R,Edwards RJ,Haynes BF,Acharya P .2021 .D614G Mutation alters SARS-CoV-2 spike conformation and enhances protease cleavage at the S1/S2 junction. Cell Rep, 34(2) : 108630.
Gupta P,Thomas SE,Zaidan SA,Pasillas MA,CoryWright J,Sebastián-Pérez V,Burgess A,Cattermole E,Meghir C,Abell C,Coyne AG,Jacobs WR,Jr. WR,Blundell TL,Tiwari S,Mendes V .2021 .A fragment-based approach to assess the ligandability of ArgB, ArgC, ArgD and ArgF in the L-arginine biosynthetic pathway of Mycobacterium tuberculosis. Comput. Struct. Biotechnol. J., 19 : 3491-3506.
Hagar M,Ahmed HA,Aljohani G,Alhaddad OA G .2020 .Investigation of some antiviral N-heterocycles as COVID 19 drug: Molecular docking and DFT calculations. Int. J. Mol. Sci, 21(11) : 3922.
Hollingsworth SA,Dror RO .2018 .Molecular dynamics simulation for all. Neuron., 99(6) : 1129-1143.
Jacobson MP,Pincus DL,Rapp CS,Day TJ,Honig B,Shaw DE,Friesner RA .2004 .A hierarchical approach to all‐atom protein loop prediction. Proteins, 55(2) : 351-367.
Kaur SP,Gupta V,Vaccine V .2020 .A comprehensive status report. Virus Res., 288 : 198114.
Konze KD,Bos PH,Dahlgren MK,Leswing K,TubertBrohman I,Bortolato A,Robbason B,Abel R,Bhat S R,Chem R .2019 .Reaction-based enumeration, active learning, and free energy calculations to rapidly explore synthetically tractable chemical space and optimize potency of cyclin-dependent kinase 2 inhibitors. , 59(9) : 3782-3793.
Kyriakidis NC,Lopez-Cortés A,González EV,Grimaldos AB,Prado EO .2021 .SARS-CoV-2 vaccines strategies: A comprehensive review of phase 3 candidates. NPJ. Vaccines, 6(1) : 28.
Lai CC,Shih TP,Ko WC,Tang HJ,Hsueh PR .2020 .Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int. J. Antimicrob. Agents, 55(3) : 105924.
Li Q .2020 .Application of fragment-based drug discovery to versatile targets. Front Mol. Biosci, 7 : 180.
Lopez Bernal J,Andrews N,Gower C,Gallagher E,Simmons R,Thelwall S,Stowe J,Tessier E,Groves N,Dabrera G,Myers R,Campbell CNJ,Amirthalingam G,Edmunds M,Zambon M,Brown KE,Hopkins S,Chand M,Ramsay M M .2021 .2 (Delta) variant. N. Engl. J. Med, 385(7) : 585-594.
Massinga Loembé M and Nkengasong JN .2021 .COVID-19 vaccine access in Africa: Global distribution, vaccine platforms and challenges ahead. Immunity, 54(7) : 1353-1362.
Mesa-Vieira C,Botero-Rodríguez F,Padilla-Muñoz A,Franco OH,Gómez-Restrepo C .2021 .The Dark Side of the Moon: Global challenges in the distribution of vaccines and implementation of vaccination plans against COVID-19. , 149 : 37-39.
Meyers J,Fabian B,Brown N B .2021 .De novo molecular design and generative models. Drug Discov. Today, 26(11) : 2707-2715.
Miar M,Shiroudi A,Pourshamsian K,Oliaey AR. Hatamjafari F .2021 .Theoretical investigations on the HOMO-LUMO gap and global reactivity descriptor studies, natural bond orbital, and nucleus-independent chemical shifts analyses of 3-phenylbenzo [d] thiazole2 (3 H)-imine and its para-substituted derivatives: Solvent and substituent effects. J. Chem. Res., 45(1-2) : 147-158.
Mohamed MA,Dirar AI,Elbadawi MA,Osman WJ,Mohammed MS,Hamdoun S MS .2017 .In silico assessment of the druggability of two novel germacranolides isolated from Capparis decidua (Forsk.) as carbonic anhydrase II inhibitors. J. App. Pharm. Sci., 7(1) : 093-097.
Munir MU,Salman S,Ahmed A,Iqbal W,Abbas Bukhari SN,Ahmad N,Ullah MI,Ahmad MM,Elsaman T,Tahir MA .2021 .Diagnosis, summary of essays and evolving approaches. Pak. J. Pharm. Sci., 34(5) : 1813-1820.
Ortega JT,Serrano ML,Pujol FH. Rangel HR .2020 .Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis. Excli J., 19 : 410-417.
Rahman S,Montero MTV,Rowe K,Kirton R,Kunik F .2021 .Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: A review of current evidence. Expert. Rev. Clin. Pharmacol, 14(5) : 601-621.
Sakkiah S,Guo W,Pan B,Ji Z,Yavas G,Azevedo M,Hawes J,Patterson TA,Hong H TA .2020 .Elucidating interactions between SARS-CoV-2 trimeric spike protein and ACE2 using homology modeling and molecular dynamics simulations. Front. Chem, 8 : 622632.
Santos LH,Ferreira RS,Caffarena ER .2053 .Integrating molecular docking and molecular dynamics simulations. Methods Mol. Biol, : 13-34.
Sastry GM,Adzhigirey M,Day T,Annabhimoju R,Sherman W .2013 .Protein and ligand preparation: parameters, protocols and influence on virtual screening enrichments. J. Comput. Aided Mol. Des, 27(3) : 221-234.
Tartof SY,Slezak JM,Fischer H JM,Hong V,Ackerson BK,Ranasinghe ON,Frankland TB,Ogun OA,Zamparo JM,Gray S JM .2021 .Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: A retrospective cohort study. The Lancet, 398(10309) : 1407-1416.
Toor HG,Banerjee DI,Darji SA,Pharmacol Eur. J. .2021 .Computational drug re-purposing targeting the spike glycoprotein of SARS-CoV-2 as an effective strategy to neutralize COVID-19.. , 890 : 173720.
Walters WP,Murcko M .2020 .Assessing the impact of generative AI on medicinal chemistry. Nat. Biotechnol, 38(2) : 143-145.
Wilson III DM,Deacon AM,Duncton MA,Pellicena P,Georgiadis MM,Yeh AP,Arvai AS,Moiani D,Tainer JA,Das D .2021 .Fragment-and structure-based drug discovery for developing therapeutic agents targeting the DNA damage response. Prog. Biophys. Mol. Biol, 163 : 130-142.
Yu R and Li P .2021 .Screening of potential spike glycoprotein/ACE2 dual antagonists against COVID19 in silico molecular docking. J. Virol. Methods, 301 : 114424.
Zeng MS,Yu WD,Wang HX,Liu JY,Xu PP JY .2021 .A potential antiviral activity of Esculentoside A against binding interactions of SARS-COV-2 spike protein and angiotensin converting enzyme 2 (ACE2). Int. J Biol. Macromol, 183 : 2248-2261.
Zhang Q,Gefter J,Sneddon WB,Mamonova T. Friedman PA .2021 .ACE2 interaction with cytoplasmic PDZ protein enhances SARS-CoV-2 invasion. , 24(7) : 102770.
Zheng Y,Zheng M,Ling X,Liu Y,Xue Y,An L,Gu N,Jin M .2013 .Design, synthesis, quantum chemical studies and biological activity evaluation of pyrazolebenzimidazole derivatives as potent Aurora A/B kinase inhibitors. Bioorg. Med, 23(12) : 3523-3530.
Zoete V,Daina A,Bovigny C,Michielin O C .2016 .SwissSimilarity: A web tool for low to ultra high throughput ligand-based virtual screening. J. Chem, 56(8) : 1399-1404.